$5.27
0.081.54%
At close: -
$5.23
-0.04-0.76%
After Hours: Nov 22, 7:49 PM EDT
Amylyx Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amylyx Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.53 | $-0.71 | 25.4 % |
Jun 2024 | 2024-08-08 | $-0.73 | $-0.73 | 0.00 % |
Mar 2024 | 2024-05-09 | $-0.12 | $-0.01 | -1100.0 % |
Dec 2023 | 2024-02-22 | $0.07 | $0.23 | -69.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-1.20M | $10.66M | -111.3 % |
Mar 2024 | 2024-05-09 | $88.64M | $98.35M | -9.87 % |
Dec 2023 | 2024-02-22 | $108.45M | $106.96M | 1.39 % |
Sep 2023 | 2023-11-09 | $102.69M | $114.26M | -10.1 % |
Amylyx Pharma (AMLX) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.53, which beat the estimate of $-0.71.
The Actual Revenue was $416K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.